It’s been a big two years for biotech investors. But if you ask Po Bronson, a partner at SOSV’s IndieBio, this trend was probably a long time coming. “Often, the implication is that everything must be overpriced,” he tells TechCrunch. “But I think more of it is that some major theses in the markets are […]
Here’s all 10 companies from IndieBio’s latest New York cohort
Most big accelerators tend to dedicate some of their resources to dauntingly hard science problems and the companies taking them on… but for SOSV’s IndieBio, it’s the primary focus. Last time we checked in with IndieBio, their companies were working on everything from lozenges to treat gum disease, to vertical farms for the sustainable production […]